Trestle Biotherapeutics

IVIVA Medical

This company develops bioartificial implantable kidneys for patients with end-stage renal disease using 3D printing and stem cell technology.

Satellite Bio

This company develops implantable bioengineered tissues to repair and restore organ function for patients with severe diseases including liver failure.

Tengion Inc

This regenerative medicine company develops replacement organs and tissues using a patient's own cells for individuals with urologic, renal, gastrointestinal, and vascular diseases.

Purespring Therapeutics

This company develops gene therapies for patients with chronic renal diseases to preserve kidney function and treat conditions like IgA nephropathy.

Estuary Biotherapeutics

This biotechnology company develops targeted genetic medicines for patients with serious kidney conditions, specifically autosomal dominant polycystic kidney disease.

Thrasos

This biotherapeutics company develops targeted peptide therapies for the prevention and treatment of kidney diseases for patients with acute and chronic renal conditions.

VenoStent

This company develops bioabsorbable vascular wraps for chronic kidney disease patients to improve the durability and success of haemodialysis access sites.

eGenesis

This company develops genetically engineered pig organs for patients suffering from organ failure and requiring transplantation.